Minias oral drops

Minias is a well-known pharmaceutical product in Italy, containing lormetazepam, used primarily for the short-term treatment of insomnia. The brand has a deep-rooted history in the Italian pharmaceutical landscape. Originally developed and marketed by brands associated with the Schering group, it is currently part of the Neopharmed Gentili portfolio.

Neopharmed Gentili is an Italian pharmaceutical company headquartered in Milan. It has grown significantly through strategic acquisitions and partnerships, establishing itself as a leader in the Italian market across various therapeutic areas. The manufacturing typically takes place in Italian facilities, ensuring compliance with European pharmaceutical standards. The company's ownership involves private equity backing, which has fueled its expansion and modernization into the mid-2020s.